학술논문
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma
Document Type
Article
Author
Source
In Clinical Lymphoma Myeloma and Leukemia February 2016 16(2):76-81
Subject
Language
ISSN
2152-2650